Abbisko Therapeutics
Clinical-stage biopharmaceutical company developing precision oncology small molecules.
Therapeutic areas
Selected products and programs
Linked curated drug profiles
Selected active clinical trials
Phase 2 · Recruiting · Advanced Pancreatic Cancer
A Study to Evaluate the Effects of Low-Fat Meal, High-Fat Meal and Omeprazole Enteric-Coated Tablets on the Pharmacokinetics of ABSK-011 Capsules in Healthy ParticipantsPhase 1 · Recruiting · Healthy Participants
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid TumorPhase 1 · Recruiting · Neoplasms
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK112 in Patients With Non-Small Cell Lung CancerPhase 1 · Recruiting · Non-Small Cell Lung Cancer
ABSK-011+BSC vs. Placebo+BSC in Previously Treated Advanced HCC With FGF19 OverexpressionPhase 2 · Recruiting · Hepatocellular Carcinoma (HCC)
A Phase 2 Clinical Study of Combination Therapy With ABSK043 and FirmonertinibPhase 2 · Recruiting · Non-Small Cell Lung Cancer With EGFR Mutation
Selected patent records
Primary and company sources
Company and pipeline information can change. Verify material decisions against the linked primary sources.
Evidence & limits
Source: Open the source record
- Record identifier
- /companies/abbisko-therapeutics/
- Event / action date
- Not separately retained
- Source update date
- Not separately retained
- Platform retrieval / processing date
- Not separately retained
What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.
Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.
Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.